418 related articles for article (PubMed ID: 27107674)
1. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
Kihara A
Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition.
Danso M; Boiten W; van Drongelen V; Gmelig Meijling K; Gooris G; El Ghalbzouri A; Absalah S; Vreeken R; Kezic S; van Smeden J; Lavrijsen S; Bouwstra J
J Dermatol Sci; 2017 Oct; 88(1):57-66. PubMed ID: 28571749
[TBL] [Abstract][Full Text] [Related]
3. Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production.
Sassa T; Ohno Y; Suzuki S; Nomura T; Nishioka C; Kashiwagi T; Hirayama T; Akiyama M; Taguchi R; Shimizu H; Itohara S; Kihara A
Mol Cell Biol; 2013 Jul; 33(14):2787-96. PubMed ID: 23689133
[TBL] [Abstract][Full Text] [Related]
4. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length.
Mizutani Y; Kihara A; Chiba H; Tojo H; Igarashi Y
J Lipid Res; 2008 Nov; 49(11):2356-64. PubMed ID: 18541923
[TBL] [Abstract][Full Text] [Related]
5. Skin permeability barrier formation by the ichthyosis-causative gene
Yamamoto H; Hattori M; Chamulitrat W; Ohno Y; Kihara A
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):2914-2922. PubMed ID: 31974308
[TBL] [Abstract][Full Text] [Related]
6. [Elucidation of the Synthetic Mechanism of Acylceramide, an Essential Lipid for Skin Barrier Function].
Ohno Y
Yakugaku Zasshi; 2017; 137(10):1201-1208. PubMed ID: 28966260
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional DEGS2 has higher hydroxylase activity toward substrates with very-long-chain fatty acids in the production of phytosphingosine ceramides.
Ota A; Morita H; Naganuma T; Miyamoto M; Jojima K; Nojiri K; Matsuda J; Kihara A
J Biol Chem; 2023 Apr; 299(4):104603. PubMed ID: 36907437
[TBL] [Abstract][Full Text] [Related]
8. Ceramide metabolism in mouse tissue.
Schiffmann S; Birod K; Männich J; Eberle M; Wegner MS; Wanger R; Hartmann D; Ferreiros N; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1886-94. PubMed ID: 23792024
[TBL] [Abstract][Full Text] [Related]
9. The effect of altered sphingolipid acyl chain length on various disease models.
Park WJ; Park JW
Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis.
Tawada C; Kanoh H; Nakamura M; Mizutani Y; Fujisawa T; Banno Y; Seishima M
J Invest Dermatol; 2014 Mar; 134(3):712-718. PubMed ID: 24008422
[TBL] [Abstract][Full Text] [Related]
11. Eleven residues determine the acyl chain specificity of ceramide synthases.
Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
[TBL] [Abstract][Full Text] [Related]
12. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
13. Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture model.
Kendall AC; Kiezel-Tsugunova M; Brownbridge LC; Harwood JL; Nicolaou A
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1679-1689. PubMed ID: 28341437
[TBL] [Abstract][Full Text] [Related]
14. Effects of (
Kováčik A; Pullmannová P; Opálka L; Šilarová M; Maixner J; Vávrová K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299088
[TBL] [Abstract][Full Text] [Related]
15. High concentration of the ester-linked ω-hydroxy ceramide increases the permeability in skin lipid model membranes.
Uche LE; Gooris GS; Bouwstra JA; Beddoes CM
Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183487. PubMed ID: 33068546
[TBL] [Abstract][Full Text] [Related]
16. Loss of ceramide synthase 3 causes lethal skin barrier disruption.
Jennemann R; Rabionet M; Gorgas K; Epstein S; Dalpke A; Rothermel U; Bayerle A; van der Hoeven F; Imgrund S; Kirsch J; Nickel W; Willecke K; Riezman H; Gröne HJ; Sandhoff R
Hum Mol Genet; 2012 Feb; 21(3):586-608. PubMed ID: 22038835
[TBL] [Abstract][Full Text] [Related]
17. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.
Hartmann D; Wegner MS; Wanger RA; Ferreirós N; Schreiber Y; Lucks J; Schiffmann S; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Jul; 45(7):1195-203. PubMed ID: 23538298
[TBL] [Abstract][Full Text] [Related]
18. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of ceramide synthase 2 in neurons suppresses neurodegeneration induced by ceramide synthase 1 deficiency.
Spassieva SD; Ji X; Liu Y; Gable K; Bielawski J; Dunn TM; Bieberich E; Zhao L
Proc Natl Acad Sci U S A; 2016 May; 113(21):5928-33. PubMed ID: 27162368
[TBL] [Abstract][Full Text] [Related]
20. The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases.
Ben-David O; Futerman AH
Neuromolecular Med; 2010 Dec; 12(4):341-50. PubMed ID: 20502986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
